Home » Topics » BioWorld Science

BioWorld Science
RSS

CanSino Biologics and PNI collaborate to develop COVID-19 RNA vaccine

May 22, 2020

PDE2 plus PDE9 inhibition synergistically improves synaptic plasticity

May 21, 2020

Topline phase IIb/III data reported for filgotinib in moderate to severely active ulcerative colitis

May 21, 2020

FDA clears Alethia's IND for phase II study of AB-16B5 in NSCLC

May 21, 2020

Anavex receives Australian clearance for first-in-human study of ANAVEX 3-71

May 21, 2020

Administration of scAAV9.CLN8 shows promise for treating CLN8-driven Batten disease

May 21, 2020

CanSino initiates phase I trial of PCV13i vaccine

May 21, 2020

Antiviral Fc-conjugate CD-377 shows potent activity against influenza

May 21, 2020

Merck & Co. describes new SCN10A channel blockers

May 21, 2020

Amygdala contains pain suppression circuit

May 21, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...